The Health Innovation Roundup, sponsored by Health Cities, is written and published weekly by Taproot Edmonton to bring you the latest news and events in research, technology, companies and people changing health for the better in Edmonton. Sign up to get the full edition delivered directly to your inbox. Use the code HEALTHCITY & you’ll get 10% off the first year. Here are some highlights from this week’s Health Innovation Roundup: Headlines The University Hospital Foundation and Roche Canada are accepting research proposals for the Alberta Roche Collaboration in Health competition, an opportunity to support research and health innovation for Alzheimer’s disease. The deadline for proposals is Jan. 7. Edmonton-based startup Medo.ai has announced a partnership with Medical Imaging Consultants aimed at revolutionizing diagnostic imaging. The first collaboration between the two is an application that simplifies thyroid examinations. Edmonton-based pharmaceutical company Pacylex recently presented the data from the first-ever clinical trial using PCLX-001, a once-per-day pill, as a treatment for patients with non-Hodgkin’s lymphoma and solid tumours. The trial was conducted at the Cross Cancer Institute, and additional studies will soon take place in Toronto and Vancouver. Dr. Lorne Tyrrell was honoured with the 2021 Henry G. Friesen International Prize in Health Research. He will receive $35,000 and deliver a series of public talks across Canada next year. The University of Alberta has partnered with the Ontario Health Research Institute and the Biotherapeutics Manufacturing Centre in Ottawa on automating the “fill and finish process” at the end of manufacturing a vaccine or other liquid drug, a stage that is often contracted out to companies in the United States or Europe. A year after professor Michael Houghton received the Nobel Prize in Physiology, the University of Alberta’s alumni magazine New Trail looked at how having a Nobel laureate can help attract students, researchers, and funding. The province announced it will now cover the cost of Sublocade, an injectable opioid treatment. The drug lasts in a person’s system for 30 days, providing stabilization, reduced craving, and enhanced protection against overdose. Gregory George Turnbull has been appointed as the new chair of the Alberta Health Services board for a three-year term effective Dec. 8. Turnbull is a former partner with McCarthy Tétrault LLP and has over 35 years of experience in corporate governance. Events Dec. 15, 10am: Alberta SPOR SUPPORT Unit Patient Engagement Journal Club Dec 16, 11am: Life Sciences Summit Info Session Dec 16, 6pm: F*** Up Night Hosted by Startup TNT and ThresholdImpact VMS Jan. 12, 12pm: Responsible AI for Business, presented by PowerEd Jan. 19-21: Rural Surgical Skills Update Jan. 26, 6:30pm: Transform Your Stress: The Resilience Advantage – Strategies for Managing Stress in Challenging Times Have a suggestion for a future edition? Send it to hello@taprootedmonton.ca for consideration. Become a “Roundup Cultivator” and sponsor Taproot Edmonton to help them chronicle health innovation in Edmonton. Learn more